OPTIMIZERx Corp is a health information services business based in the US. OPTIMIZERx shares (OPRX) are listed on the NASDAQ and all prices are listed in US Dollars. OPTIMIZERx employs 97 staff and has a trailing 12-month revenue of around $64.1 million.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Active traders
| Latest market close | $15.43 |
|---|---|
| 52-week range | $13.33 - $99.18 |
| 50-day moving average | $17.37 |
| 200-day moving average | $32.77 |
| Wall St. target price | $29.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.16 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $15.43 from 2022-10-05
| 1 week (2022-09-29) | 3.91% |
|---|---|
| 1 month (2022-09-07) | 0.26% |
| 3 months (2022-07-07) | -48.74% |
| 6 months (2022-04-07) | -59.79% |
| 1 year (2021-10-07) | -81.81% |
|---|---|
| 2 years (2020-10-07) | -29.35% |
| 3 years (2019-10-07) | 16.98% |
| 5 years (2017-10-06) | 1,051.49% |
Valuing OPTIMIZERx stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of OPTIMIZERx's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
OPTIMIZERx's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.4295. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into OPTIMIZERx's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
| Revenue TTM | $64.1 million |
|---|---|
| Gross profit TTM | $35.6 million |
| Return on assets TTM | -2.36% |
| Return on equity TTM | -5.26% |
| Profit margin | -10.89% |
| Book value | $7.75 |
| Market capitalisation | $267.1 million |
TTM: trailing 12 months
We're not expecting OPTIMIZERx to pay a dividend over the next 12 months.
OPTIMIZERx's shares were split on a 1:3 basis on 14 May 2018. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your OPTIMIZERx shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for OPTIMIZERx shares which in turn could have impacted OPTIMIZERx's share price.
Over the last 12 months, OPTIMIZERx's shares have ranged in value from as little as $13.33 up to $99.18. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OPTIMIZERx's is 0.8014. This would suggest that OPTIMIZERx's shares are less volatile than average (for this exchange).
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
Our list of 10 dividend stocks to watch in 2022.
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.